Finance

European health chief says review of new weight-loss pill will conclude by summer

Published by Global Banking & Finance Review

Posted on April 22, 2026

1 min read

· Last updated: April 23, 2026

Add as preferred source on Google
Russian military advance in eastern Ukraine ahead of Trump-Putin summit - Global Banking & Finance Review
Image depicting the recent Russian military advance into eastern Ukraine near Dobropillia, highlighting the escalating tensions ahead of the Trump-Putin summit. This event is pivotal in the ongoing conflict and impacts geopolitical discussions.
Global Banking & Finance Awards 2026 — Call for Entries

BARCELONA, April 22 (Reuters) - The head of the European Medicines Agency, Emer Cooke, said on Wednesday that the EU regulatory review of the first of a new generation of weight-loss pills would be

European Medicines Agency to Conclude Review of New Weight-Loss Pill by Summer

EU Regulatory Review of Weight-Loss Pills Nears Completion

BARCELONA, April 22 (Reuters) - The head of the European Medicines Agency, Emer Cooke, said on Wednesday that the EU regulatory review of the first of a new generation of weight-loss pills would be concluded this summer.

Statements from the European Medicines Agency

Cooke, speaking at the Reuters Pharma Europe 2026 event in Barcelona, said the review would be finished "very soon". Denmark's Novo Nordisk and U.S. rival Eli Lilly have recently launched pills in the United States.

Industry Developments

Reporting and Editing Credits

(Reporting by Maggie Fick; Writing by Ludwig Burger; Editing by Louise Heavens)

Key Takeaways

  • Emer Cooke said the EU regulatory review of a new oral weight‑loss pill will conclude “very soon,” likely before summer when regulatory decision‑making slows (reddit.com).
  • Novo Nordisk’s oral Wegovy pill was approved in the U.S. in December 2025 and plans are underway to expand into Europe; the company is investing in European production (axios.com).
  • Eli Lilly’s weight‑loss pill orforglipron (Foundayo) received expedited FDA approval in April 2026 and is already shipping in the U.S., while its EU review appears to be nearing completion (apnews.com)

References

Frequently Asked Questions

When will the European review of the new weight-loss pill be completed?
The European Medicines Agency expects to finish reviewing the new weight-loss pill by summer.
Which companies have launched the new weight-loss pills?
Novo Nordisk from Denmark and Eli Lilly from the U.S. have launched new weight-loss pills.
Who announced the timeline for the regulatory review?
Emer Cooke, head of the European Medicines Agency, announced the review timeline.
Where was the review update announced?
The update on the review was announced at the Reuters Pharma Europe 2026 event in Barcelona.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category